RIO DE JANEIRO, BRAZIL - The American pharmaceutical company Pfizer and the German laboratory BioNTech said on Wednesday, November 18th, that they proposed the Brazilian government to commercialize the BNT162b2 vaccine against Covid-19.
In the morning, the companies announced the completion of trials and that the immunizer is 95 percent effective.
"Pfizer has made a proposal to the Brazilian government, in line with the agreements that we have closed with other countries - including Latin America, which would allow to vaccinate a few millions of Brazilians in the first semester, subject to regulatory approval," reported the company in a note.
The . . .